National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

matuzumab
A humanized monoclonal antibody with antineoplastic activity. Matuzumab binds the epidermal growth factor receptor (EGFR) with high affinity, competitively blocking natural ligand binding and blocking receptor-mediated downstream signalling, resulting in impaired tumor cell proliferation. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:EMD 72000



Previous:MART-1 antigen, MART-1:26-35(27L) peptide vaccine, MART-1:27-35 peptide vaccine, mast cell stabilizer TF002, Matulane
Next:Maxidex, Maxipime, maytansine, MDR modulator CBT-1, Measurin

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov